What's driving the Cardiovascular Stents Market Growth? Prominent Players: Biotronik SE & Co. KG, Cardinal Health, Cook and more

Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the Global Cardiovascular Stents Market, predicts Fortune Business Insights in their new study. The study is titled, “Cardiovascular Stents Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025”. As per Fortune Business Insights, the market is prognosticated to exhibit 6.6% CAGR and reach a valuation of US$ 13,100.2 Mn by 2025 from US$ 7,838.9 Mn in 2017.

Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/cardiovascular-stents-market-100061

In terms of stent type, the drug-eluting stents segment is expected to hold a larger share of the market, hence booking the dominant position. This dominance is attributable to key companies introducing next-generation drugs for drug-eluting systems (DES), and is likely to continue in the coming years.

With respect to end users, the hospital's segment holds dominance in the global market as it registers the highest consumption of cardiovascular stents.

Top Leaders Overview:
Some of the leading companies in the global Cardiovascular Stents Market are

• Biotronik SE & Co. KG
• Cardinal Health
• Cook
• C. R. Bard, Inc.
• MicroPort Scientific Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Abbott
• Boston Scientific Corporation
• Medtronic
• Other players

The Global Cardiovascular Stents Market derives growth from a number of factors such as increasing focus on research and development (R&D), increasing investment from leading companies towards R&D. Besides this, increasing regulatory approvals from organizations such as the Food and Drug Administration (FDA) have contributed significantly to the global Cardiovascular Stents Market.

Furthermore, newer drug discoveries as a result of the emphasis on R&D have favored the growth of the global Cardiovascular Stents Market and are likely to boost the market in the coming years. Backed by contributions from the government as well as private organizations, the global Cardiovascular Stents Market is likely to gain traction in the coming years.
Increasing Number of Cardiovascular Cases to Fuel Demand in Market

In 2017, coronary stents surgery was the most common treatment among cardiovascular patients with a market share of 66.9%. The rising number of cardiovascular diseases worldwide is expected to drive the global market, as per analysts at Fortune Business Insights.

Besides this, huge investments made by market players in research and development on environmental and decomposable coronary stents is also anticipated to boost the market.

Unhealthy lifestyle and irregular eating habits of people have led to having increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder are continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.

However, the market may face challenges due to the presence of alternative treatment methods for vascular diseases. Again, the complexity of cardiovascular stent implantation may cause patients to opt for other treatment options and this may restrict growth in the market. Besides this, the incident of product recalls and failures may also hamper the market in the future.

Nevertheless, the emerging markets for cardiovascular stents and their rapid accent are likely to boost growth opportunities for the market in the long run. Again, the development of bioresorbable stents will help the cardiovascular stents market to grow remarkably in the future.

Alpine Stent to Open Growth Opportunities for Market in the Asia Pacific

The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.

The market for cardiovascular stents in the Asia Pacific is likely to show growth at a higher rate on account of the improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.

Various companies operating in the global cardiovascular stents market are B. Braun Melsungen AG, Cardinal Health, C. R. Bard, Inc., Terumo Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, and others. Major vendors are focusing on investing in clinical studies and research and development of better stents. At present, Boston Scientific Corporation, Abbott, and Medtronic are leading the market.

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.